Micha Y. Breakstone is the Co-founder and CEO of Somite Therapeutics, a company dedicated to utilizing AI to create human tissue for cell-based therapies. With a strong background in linguistics and NLP, Micha has held various leadership roles in companies like NeuraLight, Chorus.ai, Ginger Software, and Intel Corporation. He founded ExceLingo and managed the Syntax and Semantics Experimental Lab at MIT. Micha holds a Ph.D. in Cognitive Sciences and has a strong academic background in mathematics and computer science.